Rockefeller Capital Management
PTLA

Rockefeller Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rockefeller Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-219
Closed -$4K – 2922
2020
Q2 		$4K Sell
219
-900
-80% -$12.5K ﹤0.01% 2196
2020
Q1 		$8K Buy
1,119
+215
+24% +$2.68K ﹤0.01% 1835
2019
Q4 		$22K Buy
904
+4
+0.4% +$110 ﹤0.01% 1371
2019
Q3 		$24K Buy
+900
New +$25.3K ﹤0.01% 1172

Rockefeller Capital Management's PTLA Position: Q3 2020 in Review

Rockefeller Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 219 shares — an estimated $4K sold.

Rockefeller Capital Management first reported a position in PTLA in Q3 2019 and held it in 4 quarters. The position peaked at $24K in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Rockefeller Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 219 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4K.
  • Rockefeller Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 4 quarters.
  • Rockefeller Capital Management's Portola Pharmaceuticals, Inc. position peaked at $24K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Rockefeller Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.